داروسازی کاسپین تامین
کاسپین | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 35,240 2.97
Close Price: 35,240
Financial Ratios
AGM
Interim
2026/07/08 Fiscal Year 2026/03/2012 Month | 2025/05/17 Fiscal Year 2025/03/2012 Month | 2024/05/15 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 44.89 | 38.62 | 27.39 | |
Gross Profit to Sales | 56.86 | 44.53 | 35.31 | |
Operating Margin | 64.26 | 54.28 | 44.51 | |
Gross Profit to Sales | 66.03 | 56.35 | 46.65 | |
Net Profit to Gross Profit | 67.99 | 68.53 | 58.72 | |
Return on Assets (ROA) | 35.33 | 27.95 | 24.47 | |
Return on Capital (%) | 274.72 | 698.79 | 324.52 | |
Return on Equity (ROE) | 68.55 | 54.37 | 71.37 | |
Working Capital Return | 81.74 | 84.27 | 112.96 | |
Fixed Asset Return | 259.95 | 121.16 | 174.85 | |
Loan Benefit Assessment | 1.94 | 1.95 | 2.92 | |
Current Ratio | 2.01 | 1.77 | 1.34 | |
Quick Ratio | 1.62 | 1.36 | 0.98 | |
Liquidity Ratio | 0.18 | 0.13 | 0.08 | |
Net Working Capital | 26,684,525 | 11,608,894 | 4,022,189 | |
Current Assets Ratio | 0.86 | 0.76 | 0.85 | |
Inventory Turnover | 182.46 | 172.5 | 138.48 | |
Receivables Collection Period | 262.52 | 241.05 | 207.74 | |
Inventory to Working Capital | 0.39 | 0.53 | 1.07 | |
Working Capital Turnover | 1.82 | 2.18 | 4.12 | |
Fixed Asset Turnover | 5.79 | 3.14 | 6.38 | |
Total Asset Turnover | 0.79 | 0.72 | 0.89 | |
Debt Ratio | 0.48 | 0.49 | 0.66 | |
Debt to Equity | 0.94 | 0.95 | 1.92 | |
Long-Term Debt to Equity | 0.11 | 0.1 | 0.07 | |
Current Debt to Equity | 0.83 | 0.84 | 1.85 | |
Equity Ratio | 51.54 | 51.4 | 34.29 | |
Debt Coverage Ratio | 2.46 | 4.36 | 6.19 |
